Wall Street Analyst Thinks Viking Stock Could Soar 188%
A wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...
Determine which funds deliver the best annual risk-adjusted returns and how they stack up. Compare contenders to pick winners.
28,456 articlesA wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...
NVIDIA’s market value has climbed into the multi-trillion-dollar club as AI demand powers surge in revenue and margin...
In a high-stakes clash of industry voices, Ripple's Brad Garlinghouse pushes back against Jamie Dimon's crypto cautio...
The nuclear energy story 2026 is taking shape as decarbonization and power-hungry data demand push expansion. This gu...
Bitcoin faces a sharp deleveraging as more than $370 million in liquidations hit long bets, while corporate buyers mo...
Grab's stock move mirrors a broader tech and regional risk beat. As Uber's board change unfolds, investors weigh grow...
Zevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
coca-cola just all-time high marks a moment of momentum for KO, while PepsiCo sits below its peak with a different ri...
A bold treasury move turned Bitcoin into dividends. This practical look at a BTC monetization program reveals how lar...
Airbnb announced a $2.5 billion bond offering, sending ABNB shares down about 4% as investors weigh a shift in the co...
Rising oil prices amid escalating tensions weigh on the Dow and broader U.S. markets. This guide breaks down why ener...
In 2026, the $2,000 social security check is the main retirement income for many low- and middle-income Americans. Th...